Zagury JF - Search Results

1

New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling.

Rayar AM, Lagarde N, Martin F, Blanchard F, Liagre B, Ferroud C, Zagury JF, Montes M, Sylla-Iyarreta Veitía M. Rayar AM, et al. Among authors: zagury jf. Eur J Med Chem. 2018 Feb 25;146:577-587. doi: 10.1016/j.ejmech.2018.01.054. Epub 2018 Jan 31. Eur J Med Chem. 2018. PMID: 29407982

2

Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases.

Rayar AM, Lagarde N, Ferroud C, Zagury JF, Montes M, Sylla-Iyarreta Veitia M. Rayar AM, et al. Among authors: zagury jf. Curr Top Med Chem. 2017;17(26):2935-2956. doi: 10.2174/1568026617666170821124947. Curr Top Med Chem. 2017. PMID: 28828990 Review.

3

Nuclear Receptors Database Including Negative Data (NR-DBIND): A Database Dedicated to Nuclear Receptors Binding Data Including Negative Data and Pharmacological Profile.

Réau M, Lagarde N, Zagury JF, Montes M. Réau M, et al. Among authors: zagury jf. J Med Chem. 2019 Mar 28;62(6):2894-2904. doi: 10.1021/acs.jmedchem.8b01105. Epub 2018 Nov 6. J Med Chem. 2019. PMID: 30354114 Review.

4

NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database.

Lagarde N, Ben Nasr N, Jérémie A, Guillemain H, Laville V, Labib T, Zagury JF, Montes M. Lagarde N, et al. Among authors: zagury jf. J Med Chem. 2014 Apr 10;57(7):3117-25. doi: 10.1021/jm500132p. Epub 2014 Mar 25. J Med Chem. 2014. PMID: 24666037

5

Importance of the pharmacological profile of the bound ligand in enrichment on nuclear receptors: toward the use of experimentally validated decoy ligands.

Lagarde N, Zagury JF, Montes M. Lagarde N, et al. Among authors: zagury jf. J Chem Inf Model. 2014 Oct 27;54(10):2915-44. doi: 10.1021/ci500305c. Epub 2014 Oct 9. J Chem Inf Model. 2014. PMID: 25250508

6

Hits Discovery on the Androgen Receptor: In Silico Approaches to Identify Agonist Compounds.

Réau M, Lagarde N, Zagury JF, Montes M. Réau M, et al. Among authors: zagury jf. Cells. 2019 Nov 13;8(11):1431. doi: 10.3390/cells8111431. Cells. 2019. PMID: 31766271 Free PMC article.

7

Benchmarking Data Sets for the Evaluation of Virtual Ligand Screening Methods: Review and Perspectives.

Lagarde N, Zagury JF, Montes M. Lagarde N, et al. Among authors: zagury jf. J Chem Inf Model. 2015 Jul 27;55(7):1297-307. doi: 10.1021/acs.jcim.5b00090. Epub 2015 Jun 18. J Chem Inf Model. 2015. PMID: 26038804 Review.

8

Multiple structures for virtual ligand screening: defining binding site properties-based criteria to optimize the selection of the query.

Ben Nasr N, Guillemain H, Lagarde N, Zagury JF, Montes M. Ben Nasr N, et al. Among authors: zagury jf. J Chem Inf Model. 2013 Feb 25;53(2):293-311. doi: 10.1021/ci3004557. Epub 2013 Jan 29. J Chem Inf Model. 2013. PMID: 23312043

9

Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores.

Lagarde N, Delahaye S, Zagury JF, Montes M. Lagarde N, et al. Among authors: zagury jf. J Cheminform. 2016 Sep 6;8(1):43. doi: 10.1186/s13321-016-0154-2. eCollection 2016. J Cheminform. 2016. PMID: 27602059 Free PMC article.

10

Discriminating Agonist from Antagonist Ligands of the Nuclear Receptors Using Different Chemoinformatics Approaches.

Lagarde N, Delahaye S, Jérémie A, Ben Nasr N, Guillemain H, Empereur-Mot C, Laville V, Labib T, Réau M, Langenfeld F, Zagury JF, Montes M. Lagarde N, et al. Among authors: zagury jf. Mol Inform. 2017 Oct;36(10). doi: 10.1002/minf.201700020. Epub 2017 Jul 3. Mol Inform. 2017. PMID: 28671755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters